Skip to main content

CRI Speaks

Let's spread the word about Immunotherapy! Click to share this page with your community.

Upcoming CRI Speaks

June 21, 20199:00 AM

Immuno-Oncology: A Future Look

Hosted by the Cancer Research Institute this intimate, invitation-only event for media and health care investment analysts will explore what’s next in the IO field.

Past CRI Speaks

May 07, 20197:00 AM
CRI Speaks

Cancer Progress 2019

Drs. Jill O'Donnell-Tormey and Vanessa M. Lucey are participating in panel discussions at Cancer Progress.

April 11, 20198:00 AM
CRI Speaks

Kraft Precision Medicine Accelerator Workshop

Laura Peace, Consultant, Head of Clinical Alliances, Clinical Accelerator, participates in a panel discussion, 10:30 a.m.-11:15 a.m.

March 29, 201912:00 PM
CRI Speaks

2019 AACR Annual Meeting

Update on a CRI-funded pancreatic cancer trial led by Robert H. Vonderheide, M.D., D.Phil, on March 31 at 2:27 p.m.

March 03, 201912:00 PM
CRI Speaks

Inaugural Festival of Biologics San Diego

CEO Jill O’Donnell-Tormey, Ph.D., participates in the Women in Science panel on March 3, 2019 at 2:30 p.m. 

June 01, 20181:00 PM
CRI Speaks

2018 ASCO Meeting

CRI scientists present at the Annual Meeting of the American Society of Clinical Oncologists. CRI provides a daily recap of new work coming out of the conference. 

April 14, 20188:00 AM
CRI Speaks

2018 AACR Annual Meeting

CRI-funded and -affiliated scientists and clinicians showcased at the American Association of Cancer Research Annual Meeting on April 14-18, 2018, in Chicago.

April 12, 20187:15 AM
CRI Speaks

Cancer Advance Boston

On April 12, our chief medical officer, Aiman Shalabi, is a featured expert on the panel, “Immuno-Oncology: Challenges & Opportunities”.

March 19, 20187:00 AM
CRI Speaks

Fortune Brainstorm HEALTH 2018

Dr. Jill O’Donnell-Tormey, CEO and director of scientific affairs, participates in the 'Weaponizing Your Own Body' panel on Tuesday, March 20, 2018 at 7:45 am.

January 22, 20184:30 PM
CRI Speaks

Immuno-Oncology Frontiers World

Dr. Vanessa Lucey, associate director, CRI Venture Fund & Clinical Accelerator, speaks during the "Back to Basics" session on January 23, 2018 at 2:00 p.m. 

January 09, 20187:00 AM
CRI Speaks

ENDPOINTS Executive Breakfast

Aiman Shalabi, Chief Medical Officer, is a panelist at the ENDPOINTS Executive Breakfast in San Francisco. This year's topic: “Where is the cancer R&D revolution headed?”

*Immunotherapy results may vary from patient to patient.